Suppr超能文献

肾病综合征中Hageman因子(因子XII)的尿排泄及无功能Hageman因子的存在。

Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome.

作者信息

Saito H, Goodnough L T, Makker S P, Kallen R J

出版信息

Am J Med. 1981 Mar;70(3):531-4. doi: 10.1016/0002-9343(81)90575-1.

Abstract

Acquired deficiencies of functional Hageman factor (factor XII) and prekallikrein, proteins involved in the plasma kinin-generating system, have been previously reported in the nephrotic syndrome. The basis for these changes, however, is not fully understood. We have examined the levels of Hageman factor and prekallikrein by functional and radioimmunoassays in plasmas and urines of 11 patients with the nephrotic syndrome. All 11 patients had decreased titers of plasma Hageman factor activity (mean +/- standard deviation (SD), 0.29 +/- 0.15 U/ml), but essentially normal titers of immunoreactive Hageman factor (0.68 +/- 0.23 U/ml). The ratio of immunoreactive Hageman factor to functional Hageman factor (2.63 +/- 0.86) was significantly higher than that in nine control patients (1.08 +/- 0.17). Since no circulating anticoagulants against Hageman factor were detected, these data suggest the presence of nonfunctional (altered) Hageman factor in plasmas of patients with the nephrotic syndrome. Urinary excretion of Hageman factor was present in six patients but did not appear to account for the reduced plasma Hageman factor activity. Urinary Hageman factor in one patient had the same size as plasma Hageman factor as assessed by gel filtration and sucrose density gradient centrifugation. The titers of plasma prekallikrein were within the normal range. These studies indicate urinary excretion of Hageman factor and alterations in the functional sites of plasma Hageman factor molecules in the nephrotic syndrome. Whether these changes are related to the pathogenesis of the nephrotic syndrome remains to be determined.

摘要

先前已有报道称,肾病综合征患者存在功能性哈格曼因子(因子 XII)和前激肽释放酶(参与血浆激肽生成系统的蛋白质)的后天性缺乏。然而,这些变化的基础尚未完全明确。我们通过功能测定和放射免疫测定法,检测了 11 例肾病综合征患者血浆和尿液中哈格曼因子和前激肽释放酶的水平。所有 11 例患者血浆哈格曼因子活性滴度均降低(平均值±标准差(SD),0.29±0.15 U/ml),但免疫反应性哈格曼因子滴度基本正常(0.68±0.23 U/ml)。免疫反应性哈格曼因子与功能性哈格曼因子的比值(2.63±0.86)显著高于 9 例对照患者(1.08±0.17)。由于未检测到针对哈格曼因子的循环抗凝剂,这些数据表明肾病综合征患者血浆中存在无功能(改变)的哈格曼因子。6 例患者出现哈格曼因子尿排泄,但这似乎并不能解释血浆哈格曼因子活性降低的原因。通过凝胶过滤和蔗糖密度梯度离心评估,1 例患者的尿哈格曼因子与血浆哈格曼因子大小相同。血浆前激肽释放酶滴度在正常范围内。这些研究表明肾病综合征患者存在哈格曼因子尿排泄以及血浆哈格曼因子分子功能位点的改变。这些变化是否与肾病综合征的发病机制有关仍有待确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验